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A severe systemic inﬂammatory response is usually seen after burn injury. IL-18 enhances the Th1 immune responses in bacterial
and viral infections. In order to evaluate the IL-18 serum levels as well as IL-6 and TNF-α at the 48th hour postburn, serial serum
samples of 8 burned patients were analyzed. 8 moderately burned patients were included into the study. Serum samples were taken
at admission at the 48th hour of postburn. IL-6, IL-18, and TNF-α serum levels were analyzed. Total mean burned surface area
(TBSA)was24.6±5.7% andmean BMI(bodymassindex) was 24.5±3.4. Thepatients’age rangedfrom17to38(mean 26.3±7.4)
years. An increase in sera IL-6, IL-18, and TNF-α was detected at the 48th hour postburn (P<. 0001). All patients survived. A
marked increase in serum levels of IL-18 as well as the other cytokines evaluated was observed in the moderately burned patients.
These three parameters were highly correlated with each other (r>0.9a n dP<. 001). This is the ﬁrst study that shows an increase
in serum IL-18 levels at the early postburn period.
Copyright © 2006 Y. K. Coban and M. Aral. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
INTRODUCTION
Seriousthermalinjuryleadstoincreasedvascularpermeabil-
ity and subsequently hypovolemic shock, skeleto-muscular
proteolysis, lipolysis, gluconeogenesis, increased metabolic
rate, and a severe systemic inﬂammatory response. This re-
sponse is induced by local infections, surgical procedures,
and inﬂammatory mediators such as histamine, serotonin,
bradykinin, prostaglandins, leukotrienes, and platelet acti-
vator factor. Cytokines are the primary mediators of the in-
ﬂammatory response to injury. Cytokines are a group of pro-
teins with autocrine and endocrine activities which provide
communication among cells of tissues of the man. Active in
minute quantities, the cytokines activate and regulate home-
ostasis and cellular repair through eﬀects on cell growth and
diﬀerentiation and on receptor expression and cell-mediated
immunity.
The trauma of burn injury induces a distinct inﬂam-
matory response which is characterized by activation of all
inﬂammatory pathways, dysregulation of cell-mediated im-
munity, and alterations of mediators of the immune system
involving cytokines, growth factors, vascular endothelium,
and diﬀerent immunocompetent cell populations. Various
cytokines, such as interleukin IL-1, IL-6, and tumor necro-
sis factor alfa (TNF-α), have been reported as markers of
the severity of burn injury that might have prognostic value
[1, 2]. Large degree of variability in hormone and cytokine
plasma levels in a burn patient group has been reported [3].
The incidence of systemic inﬂammatory response syndrome
(SIRS) and multiple organ dysfunction syndrome (MODS)
has been found as three times increased in patients with to-
tal burned surface area (TBSA) > 30% compared to patients
withTBSA< 30% [4].Some proinﬂammatory markers,such
as IL-6, procalcitonin, and IL-2 serum levels were reported
signiﬁcantly higher in severely burned patients than moder-
ately burned patients. C-reactive protein (CRP) concentra-
tions in moderately burned patients decreased continuously
during postburn healing period, while the levels of severely
burned patients remained signiﬁcantly elevated [5, 6]. Cur-
rent literature shows that there is an extended inﬂammatory
response in severely burned patients.
Among the cytokines, IL-6 was pointed as the main me-
diator in burn injury by the body response within days of 2–
21postinjury[6].AlackordelayintheplasmaIL-10elevated
levels and burn sepsis has been reported as closely related at
the early postinjury period [5]. An increase in serum levels
of TNF-α, IL-6, and IL-8 were detected at the early postburn
period [7]. TNF-α belongs to a family inducing cytotoxic
reactions, whereas IL-6 stimulates humoral immunity. Al-
though the hypercytokinemia associated with burn injuries2 Mediators of Inﬂammation
Table 1: Demographics of patients, burn score (TBSA), causes of burns, body mass index (BMI), and IL-6, IL-18 as well as TNF-α serum
levels at admission and at 48th postburn hour.
Causes of burns Age TBSA BMI IL-6(pg/mL) TNF-α(pg/mL) IL-18(pg/mL)
year/gender Admission 48th hour Admission 48th hour Admission 48thhour
Scalding 23/male 16 23 12.81 36.82 4.63 14.65 14.6 58.6
Scalding 20/female 20 22 19.41 40.27 5.57 21.52 16.6 57.9
Flames 34/male 24 27 20.42 42.82 6.28 23.89 16.1 64.2
Contact 21/male 26 28 22.44 44.64 6.83 27.44 23.6 73.1
Explosion 17/male 22 19 22.94 64.36 7.07 33.36 33.0 94.5
Electricity 26/female 32 23 23.44 68.03 7.31 34.54 38.1 109.4
Scalding 31/male 33 25 35.44 83.70 7.79 48.75 41.1 117.4
Scalding 38/female 24 29 51.72 87.97 8.84 78.34 43.5 125.4
Mean ± standard deviation (SD) 24.5 ± 3.42 4 .6 ±5.7 26.1 ±12.15 8 .5 ±20.26 .8 ±1.33 5 .3 ±20.22 8 .3 ±12.08 7 .6 ±27.6
Control group values for BMI, IL-6, TNF-α, and IL-18 were as follows: 23.3 ±4.3, 24.1 ±8.1pg/mL,4.6 ±.5pg/mL,and25.1 ±8.4pg/mL,respectively .
isawell-knownclinicalentity,theplasmalevelsofIL-18were
notstudiedinburnedpatientsbefore.Developmentofanex-
tended inﬂammatory response which covers not only proin-
ﬂammatory but also immunoinhibitory aspects is observed
as diﬀerent in moderately and severely burned patients. IL-
18 is required for facilitating neutrophil-dependent injury
through suppressing anti-inﬂammatory cytokine expression
during ischemia/reperfusion injury [8]. The inclusion of IL-
18 to study depends on the fact that burn injury is accompa-
nied bytissuehypoxia, reperfusioninjury, induction, andac-
tivation of leukocytes. Endogenous IL-18 plays an important
role in the early antibacterial host response [9]. This study
aimed to evaluate the early changes of IL-18, IL-6, and TNF-
α in serum after burn injury in moderately burned patients.
MATERIALS AND METHODS
The informed consent of the patients or their families and
the approval of the Ethics Committee of Sutcu Imam Uni-
versity, School of Medicine, were obtained before the study.
8 patients admitted within 2 hours of burn injury were seg-
regated based on burn size. The ﬁrst serum sample was ob-
tained from each patient at time of admission to the KSU
Medical Research Hospital. The second serum sample was
obtained at the 48th hour of postburn injury. The diagnoses
of systemic inﬂammatory response syndrome (SIRS), sep-
sis, septic shock, and multiple organ dysfunction syndrome
(MODS) were based on the criteria of the College of Chest
Physicians/Society of Critical Care Medicine (ACCP/SCCM)
[10]. A control group consisting of 8 healthy persons was
chosen from the volunteers which matched the study group.
Any patient who had chronic obstructive pulmonary disease
or an inhalation injury was excluded from the study. And
any patient with cigarette smoking history was also excluded
from the study.
Measurementofcytokinelevelsinsera
Blood (10mL) was collected, allowed to clot at room tem-
perature for 30 minutes, and was then centrifuged for 10
minutes, at 1000xg. Sera were quickly frozen at −70 ◦Ca n d
stored until the day of analysis. Serum IL-6 levels were mea-
sured by ELISA (enzyme-linked immunosorbent assay) us-
ing IL-6 EASIA kit (enzyme ampliﬁed sensitivity immunoas-
say, BioSource Europe S A, Nivelles, Belgium). This assay de-
tected only human IL-6 and the minimum detectable con-
centration in our laboratory was 4.6pg/mL.
SerumTNF-αlevelsweremeasuredbyELISAusingTNF-
α EASIA kit. This assay detected only human TNF-α and
theminimumdetectableconcentrationinourlaboratorywas
4.6pg/mL.
Serum IL-18 levels were measured by an ELISA IL-18 kit
(Biosource Europe S A, Nivelles, Belgium). This assay de-
tected only human IL-18 and the minimum detectable dose
in our laboratory was 14.6pg/mL.
Statisticalanalysis
All the data were expressed as mean ± standard deviation (S
D). The Students t test was used to test for signiﬁcant diﬀer-
ences, the Spearman equation for correlations. In all tests, P
values of less than .05 were considered signiﬁcant.
RESULTS
The subjects were 8 burn patients with a TBSA of 15% or
more, from whom blood specimens could be repeatedly ob-
tained beginning immediately after the injury. All the pa-
tients survived. TBSA was mean 24.6 ± 5.73% and mean
BMI (body mass index) was 24.5 ± 3.38. The patients ages
ranged from 17 to 38 (mean 26.3 ± 7.4). Table 1 shows the
burn demographics of the study group and the causes of the
burn injury of the cases. TBSA of the burn injury ranged
from 16 to 33%. Among these 8 patients, 6 recovered within
4 weeks and 2 patients who needed a skin graft operation
recovered within 5 weeks. In these patients, skin grafting
was applied for third degree burns at the third week of the
admissions. An uneventful healing were achieved in all the
patients within three weeks. Two of the patients in which
wound cultures were positive for Staphylococcus aureus and
Pseudomonas aureginosa had septic events during the healing
course (Table 1).Y. K. Coban and M. Aral 3
Mean IL-6 serum level at admission was 26.1 ±
12.1pg/mL (min: 12.8 and max: 51.7). Mean serum IL-18
levelatadmissionwas28.3±11.9pg/mL(min:14.6andmax:
43.5).MeanserumTNF-αlevelwas6.8±1.3pg/mL(min:4.6
and max: 8.8).
Mean serum IL-6 level at the 48th hour of postburn pe-
riod was 59 ± 20pg/mL (min: 36.8 and max: 88). Mean
serum IL-18 level at the 48th hour of postburn period was
87.6 ± 27.6pg/mL (min: 57.9 and max: 125.4). Mean serum
TNF-α level at the 48th hour of the postburn period was
35.3 ±20.1pg/mL (min: 14.65 and max: 78.34).
Signiﬁcant increases in sera IL-6, IL-18, and TNF-α were
detected at the 48th hour postburn (P<. 0001). The IL-6,
IL-18, and TNF-α levels at admission did not show any dif-
ference from the control group (P>. 05). Table 1 shows the
results at ﬁrst admission and 48th hour in postburn period.
With using Spearman test, it was seen that these three
parameters were highly correlated with each other (r>0.9
and P<. 001). There was no MODS event in any patient
who experienced sepsis during healing course in the study
group.
DISCUSSION
IL-18 enhance the IL-12 driven Th1 immune responses in
bacterial and viral infections and is therefore essential for
host defence [11]. IL-18 is a multifunctional cytokine that
aﬃliates to the IL-1 cytokine family and is produced by im-
munocompetent and nonimmunocompetent cells such as
keratinocytes, intestinal and airway epithelial cells (entry of
microbes and allergens to body) even under normal phys-
iological conditions [12, 13]. The aim of this study was to
investigate the course of a proinﬂammatory cytokine IL-18
in burned patients at the ﬁrst 48 hours of postburn period.
Previous studies have shown that increased serum IL-6 and
TNF-αlevelsarefoundpostburn[5–7].IL-18(alsoknownas
interferon-gamma inducing factor, or IGIF), a new molecule
has now been added to the very short list of interferon reg-
ulators. Either independently or in synergy with IL-12, the
eﬀects of IL-18, through its induction of IFN-gamma, can
lead to a rapid activation of the monocyte/macrophage sys-
tem with an upregulation of their innate immune capabili-
ties [13–15]. IL-18 itself is induced by stressful stimuli (i.e.,
bacterial or neurogenic signals) [16]. IL-18 has also been im-
plicatedin killingmediated bytheFasligand(FasL).FasLisa
tightly regulated 40kDa member of the TNF superfamily of
molecules[17].IL-18upregulatesbothFasLandIFN-gamma
productioninTcellsandtheIFN-gammaproducedmaywell
induce Fas antigen on a variety of cell types. Thus IL-18, via
IFN-gamma induction, could be considered a molecule that
provides both the means (FasL) and the opportunity (Fas)
for instigating apoptotic cell death [18].
This study is the ﬁrst to show that serum IL-18 lev-
els increases within 48 hours postburn. It is well known
that cigarette smoking may aﬀect IL-18 levels by amplify-
ing the airway inﬂammation associated with asthma [19].
We exclude such a confusing comorbid situations, as no
patient who had chronic obstructive pulmonary disease or
inhalation injury included in the study. The purpose of mea-
suring BMI depends on the fact that higher circulating con-
centrations of the proinﬂammatory cytokines interleukin-6,
IL-8, and IL-18 as well as C-reactive protein were found in
obesemen[20].AlthoughBMIofthestudygrouprangedbe-
tween normal and obese (mean 24.5±3.38), we do not think
that this parameter had a profound eﬀect on IL-18 levels at
thepostburnperiod, astheIL-18levelsofﬁrstblood samples
did not show any heterogenety. TNF-α production has been
previously shown to correlate with the release of lipopolysac-
charide and IL-6 [21]. In the present study, this was con-
ﬁrmed, because both TNF-α and IL-6 levels were found as
elevated. A further implication of this study is that detection
of increased serum IL-18 after burn injury signiﬁcantly cor-
relates with TNF-α and IL-6.
Experimentally, it was shown that IL-18 therapy de-
creased the mortality of burn-injured mice followed by a se-
vere infection, whereas it unexpectedly increased the mor-
tality of burned mice with a mild infection [22]. Neutralisa-
tion of IL-18 during experimental lethal endotoxemia pro-
tects mice against lethal eﬀects of lipopolysaccaride which
is a composition of some bacteria [23]. Burn sepsis usually
occurs by bacteriemia. IL-18 has also been shown to im-
prove the early defence system against inﬂuenza virus infec-
tion [24]. IL-18 also exerts proinﬂammatory properties by
inducing the production of IL-1β,T N F - α,I L - 6 ,a n dI F N - γ
[25].TheobservedelevationofIL-18serumlevelsmaybere-
latedtobacteriemicand/orneurogenicstimuliinclinicalsce-
nario of burned patient. With these ﬁndings obtained from
this study, it is too early to draw conclusions about the rela-
tionship between IL-18 and other parameters evaluated. Fu-
ture studies will delineate the role of IL-18 in the pathophys-
iology of postburn period.
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